These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis. Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451 [TBL] [Abstract][Full Text] [Related]
27. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Muriel P; Moreno MG; Hernández Mdel C; Chávez E; Alcantar LK Basic Clin Pharmacol Toxicol; 2005 May; 96(5):375-80. PubMed ID: 15853930 [TBL] [Abstract][Full Text] [Related]
28. Colchicine, serum albumin, and alkaline phosphatase. Kershenobich D; Uribe M; Suarez GI; Tamayo RP; Rojkind M Ann Intern Med; 1978 Jul; 89(1):144. PubMed ID: 352218 [No Abstract] [Full Text] [Related]
29. [Colchicine--mechanism of activity and its utilization in hepatology practice]. Simon K; Gładysz A Przegl Lek; 1992; 49(7):234-6. PubMed ID: 1297154 [No Abstract] [Full Text] [Related]
31. Colchicine therapy for hepatic fibrosis in a dog. Boer HH; Nelson RW; Long GG J Am Vet Med Assoc; 1984 Aug; 185(3):303-5. PubMed ID: 6469833 [No Abstract] [Full Text] [Related]
32. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]. Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496 [TBL] [Abstract][Full Text] [Related]
33. [Blood serum level of free and total hydroxyproline in liver cirrhosis]. Zmudziński J; Potkańska A; Kapołka D; Chociłowska D; Malinowski S Pol Tyg Lek; 1982 Jun; 37(19-20):549-51. PubMed ID: 7177944 [No Abstract] [Full Text] [Related]
34. [Urinary hydroxyproline excretion in liver cirrhosis]. Bretzke G; List A; Stahl E Z Gesamte Inn Med; 1978 Mar; 33(5):148-50. PubMed ID: 645148 [TBL] [Abstract][Full Text] [Related]
35. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial. Adhami JE; Basho J Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762 [TBL] [Abstract][Full Text] [Related]
36. Therapy for hepatic fibrosis. Brenner DA; Alcorn JM Semin Liver Dis; 1990 Feb; 10(1):75-83. PubMed ID: 2186490 [TBL] [Abstract][Full Text] [Related]
38. [Therapy of liver cirrhosis]. Paumgartner G Z Gastroenterol Verh; 1983 Apr; 18():63-9. PubMed ID: 6192610 [No Abstract] [Full Text] [Related]
39. The effect of colchicine on the accumulation of hydroxyproline and on lung compliance after irradiation. Dubrawsky C; Dubravsky NB; Withers HR Radiat Res; 1978 Jan; 73(1):111-20. PubMed ID: 622454 [No Abstract] [Full Text] [Related]
40. Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma. Harris ED; Hoffman GS; McGuire JL; Strosberg JM Metabolism; 1975 Apr; 24(4):529-35. PubMed ID: 1117843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]